eMemory Technology (3529)
Taipei Exchange · Taiwan · prices in TWD · close of 27 Oct 2026
Key indicators
| Last close | TWD 2,515.00 |
|---|---|
| 52-week range | 1,490.00 – 4,785.00 |
| Return, 1 month / 3 months | −22.1% / +3.5% |
| Return, 1 year / 3 years | +16.1% / +20.8% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 73.0% |
| Worst drawdown (1 year) | -55.4% |
| Average daily value traded | 3,350.10M TWD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
eMemory Technology develops embedded non-volatile memory technology that is licensed as intellectual property for use inside integrated circuits. Chip designers and semiconductor foundries use its memory blocks in products such as microcontrollers, display drivers and power management chips, where small amounts of memory must be built into the silicon. The company is based in Hsinchu, Taiwan, and works closely with manufacturing partners so that its technology can be produced in their processes.
The shares are listed on the Taipei Exchange in Taiwan under the code 3529, and the price on this page is in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
eMemory Technology (3529) trades on the Taipei Exchange in Taiwan. It last closed at TWD 2,515.00 on 27 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 687 of 1,093 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.1% and over the last three months it rose 3.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taipei Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 37 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.3% | ||
| From 52-week high | -46.5% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.5% | ||
| 6-month return | -37.4% | ||
| 12-month return, skipping the last month | 49.1% | ||
| Stability (higher is calmer) | 14 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.4% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 3,350.10M TWD | ||
| Zero-volume days | 1.7% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.3% |
|---|---|
| 1 month | −22.1% |
| 3 months | +3.5% |
| 6 months | −37.4% |
| 1 year | +16.1% |
| 3 years | +20.8% |
| 5 years | +10.0% |
Signals
| 50-day / 200-day average | 2,700.30 / 2,743.56 |
|---|---|
| Golden / death cross (60 days) | Death, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 155.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | TWD 20.5000 |
| 26 Jun 2025 | TWD 21.9971 |
| 4 Jul 2024 | TWD 17.4990 |
| 29 Jun 2023 | TWD 20.4994 |
| 30 Jun 2022 | TWD 13.9998 |
| 16 Jul 2021 | TWD 8.9990 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taipei Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.